Macrophage activation by endogenous danger signals
- PMID: 18161744
- PMCID: PMC2724989
- DOI: 10.1002/path.2284
Macrophage activation by endogenous danger signals
Abstract
Macrophages are cells that function as a first line of defence against invading microorganisms. One of the hallmarks of macrophages is their ability to become activated in response to exogenous 'danger signals'. Most microbes have molecular patterns (PAMPS) that are recognized by macrophages and trigger this activation response. There are many aspects of the activation response to PAMPS that are recapitulated when macrophages encounter endogenous danger signals. In response to damaged or stressed self, macrophages undergo physiological changes that include the initiation of signal transduction cascades from germline-encoded receptors, resulting in the elaboration of chemokines, cytokines and toxic mediators. This response to endogenous mediators can enhance inflammation, and thereby contribute to autoimmune pathologies. Often the overall inflammatory response is the result of cooperative activation signals from both exogenous and endogenous signals. Macrophage activation plays a critical role, not only in the initiation of the inflammatory response but also in the resolution of this response. The clearance of granulocytes and the elaboration of anti-inflammatory mediators by macrophages contribute to the dissolution of the inflammatory response. Thus, macrophages are a key player in the initiation, propagation and resolution of inflammation. This review summarizes our understanding of the role of macrophages in inflammation. We pay particular attention to the endogenous danger signals that macrophages may encounter and the responses that these signals induce. The molecular mechanisms responsible for these responses and the diseases that result from inappropriately controlled macrophage activation are also examined.
2007 Pathological Society of Great Britain and Ireland
Conflict of interest statement
No conflicts of interest were declared.
Figures

Similar articles
-
Macrophages: The Good, the Bad, and the Gluttony.Front Immunol. 2021 Aug 12;12:708186. doi: 10.3389/fimmu.2021.708186. eCollection 2021. Front Immunol. 2021. PMID: 34456917 Free PMC article. Review.
-
The role of macrophages in inflammatory bowel diseases.Expert Rev Mol Med. 2009 May 14;11:e14. doi: 10.1017/S1462399409001069. Expert Rev Mol Med. 2009. PMID: 19439108 Review.
-
[Combination of two signals of danger--a principal cause of activation of chronic inflammatory processes].Fiziol Cheloveka. 2012 Sep-Oct;38(5):83-9. Fiziol Cheloveka. 2012. PMID: 23101244 Review. Russian.
-
Targeting Macrophage Polarization in Infectious Diseases: M1/M2 Functional Profiles, Immune Signaling and Microbial Virulence Factors.Immunol Invest. 2024 Oct;53(7):1030-1091. doi: 10.1080/08820139.2024.2367682. Epub 2024 Jun 24. Immunol Invest. 2024. PMID: 38913937 Review.
-
Protective and pathogenic functions of macrophage subsets.Nat Rev Immunol. 2011 Oct 14;11(11):723-37. doi: 10.1038/nri3073. Nat Rev Immunol. 2011. PMID: 21997792 Free PMC article. Review.
Cited by
-
Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.J Neurosci. 2012 Dec 5;32(49):17824-9. doi: 10.1523/JNEUROSCI.1504-12.2012. J Neurosci. 2012. PMID: 23223301 Free PMC article.
-
SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages.Biochim Biophys Acta. 2013 Feb;1832(2):336-46. doi: 10.1016/j.bbadis.2012.10.012. Epub 2012 Oct 30. Biochim Biophys Acta. 2013. PMID: 23123599 Free PMC article.
-
Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.Acta Biomater. 2012 Sep;8(9):3218-27. doi: 10.1016/j.actbio.2012.05.027. Epub 2012 May 29. Acta Biomater. 2012. PMID: 22659176 Free PMC article.
-
Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.Mol Cancer Res. 2012 Jun;10(6):727-38. doi: 10.1158/1541-7786.MCR-11-0604. Epub 2012 Apr 24. Mol Cancer Res. 2012. PMID: 22532586 Free PMC article.
-
Abnormal cell responses and role of TNF-α in impaired diabetic wound healing.Biomed Res Int. 2013;2013:754802. doi: 10.1155/2013/754802. Epub 2013 Jan 20. Biomed Res Int. 2013. PMID: 23484152 Free PMC article. Review.
References
-
- Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol. 1984;2:283–318. - PubMed
-
- Mege JL, Meghari S, Honstettre A, Capo C, Raoult D. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis. 2006;6:557–569. - PubMed
-
- O’Garra A, Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol. 2007;7:425–428. - PubMed
-
- Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J. 2006;20:1589–1598. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources